Bioventix PLC - London-based biotechnology company - Reports 9.8% decline in profit in the six months ending December 31, to GBP3.7 million from GBP4.1 million year-on-year. Revenue rises 1.3% to GBP5.2 million from GBP5.1 million. First interim dividend increases 20% to 43 pence per share from 36p per share. "We remain optimistic about our troponin revenues and the success of these high sensitivity troponin products around the world," company says.
Current stock price: 4,812 pence
Year-to-date change: down 6.2%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.